Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

8-Week aerobic program boosts walking and hand function in MS patients

NCT ID NCT07325019

Symptom relief Sponsor: Lokman Hekim University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether 8 weeks of aerobic exercise can improve movement and daily function in people with Multiple Sclerosis (MS). 30 adults with MS were randomly placed into an exercise group or a control group. The exercise group showed significant improvements in walking distance, hand dexterity, and mobility compared to the control group. The goal was to ease symptoms and improve quality of life, not to cure the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Feb 2025

Finished

Jun 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having a definite diagnosis of MS according to McDonald criteria, * Being aged between 20 and 50, * Having a Standardised Mini Mental Test (SMMT) score of ≥24, * Having an Expanded Disability Status Scale (EDSS) score between 0 and 4.0, * Having no other serious health problems that would prevent exercise, * Having had no change in medication in the last 6 months. Exclusion Criteria: * Having experienced an MS relapse within the last 6 months, * Having an orthopaedic or systemic problem that would prevent participation in the exercises, * Having another known neuromuscular disorder besides MS, * Having received immunomodulatory treatment within the last 6 months, * Having a cardiopulmonary disorder that could prevent participation in the exercise, * Being pregnant or breastfeeding. Criteria for exclusion from the study: * Failure to attend three consecutive sessions of the exercise programme * Change in ongoing pharmacological treatment or discontinuation of pharmacological treatment * Development of a history of MS attacks or deterioration in health status

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Disease Progression multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

Contacts and locations

Locations

  • Lokman Hekim University

    Ankara, 06000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.